Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- Fondation Leducq
- U.S. Department of Veterans Affairs
- American Heart Association
This publication has 32 references indexed in Scilit:
- Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trialsThe Lancet, 2015
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 2015
- Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population studyHeart, 2010
- A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analysesThe Lancet, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation, 2002
- Primary Prevention of Coronary Heart Disease: Guidance From FraminghamCirculation, 1998
- Guide to Primary Prevention of Cardiovascular DiseasesCirculation, 1997